A California woman says in her lawsuit that she trusted the man because he was an “old friend” from high school. She’s out ...

Charlotte City Council approved the purchase of 22 miles of the O-line right-of-way to move forward with the Red Line commuter rail project, which will connect the northern towns of Mecklenburg County ...

The pilot of a float plane that crashed on a remote island near Washington’s border with Canada changed course to avoid a thunderstorm before it went down ...

Emma Brookes speaks with Carl Braun of Coldwell Banker Commercial Elite on North American site selection trends, secondary ...

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

To identify the top-performing companies in the U.S., TIME partnered with Statista to evaluate and rank the most prominent firms in the country based on employee satisfaction, fin ...

Carver head basketball coach Nathaniel Roche believes that the Rams’ heartbreaking 1-point loss to Eleanor McMain in the 2021 ...

Employees train on equipment in the Education Building, one of 21 structures on Roche Diagnostics’ 170-acre Hague Road campus. (IBJ photo/Chad Williams) Swiss health care giant Roche continues an ...

Roche is trying to break into a relatively new market for medicines targeting a genetic mutation known as KRAS G12C that occurs in about 14% of non-small cell lung cancer cases. When working properly, ...

Roche's chief medical officer, Levi Garraway. Roche has thrown down the gauntlet to Amgen and Bristol Myers Squibb with new phase 3 data for its experimental KRAS G12C inhibitor, divarasib, which it ...

Roche’s investigational KRAS G12C inhibitor has beaten Amgen’s Lumakras and Bristol Myers Squibb’s Krazati in a phase 3 trial, furthering its ambitions to establish divarasib as a new standard of care ...